Department of Health

DC Agency Top Menu

-A +A
Bookmark and Share

Influenza Surveillance and Reporting

DC Influenza Surveillance Data

DC DOH produces regular influenza surveillance reports during the influenza season. 

►2017 - 2018 reports by MMWR week: 

Surveillance and Reporting

Influenza Surveillance

Routine surveillance in DC commenced on October 1, 2017 and will continue until May 19, 2018. The Division of Epidemiology- Disease Surveillance and Investigation (DE-DSI) will continue to collect data on aggregate confirmed influenza cases and influenza-like-illness (ILI) on a weekly basis. Archived reports from previous seasons can be found here.

Healthcare providers that would like to help strengthen influenza-like-illness surveillance in the District can enroll to be part of the CDC’s ILINet surveillance program. For more information on what ILINet is, who is eligible, and why you should participate, take a look at this fact sheet.

Please contact us at [email protected] to learn more or if you would like to enroll.

Virologic Surveillance and Influenza Specimen Submission by DC Clinical Laboratories

For larger health care practices and facilities, regular submission of a subset of your collected influenza specimens to the DC Public Health Laboratory (PHL) for virologic surveillance is strongly encouraged. Virologic surveillance is an essential part of the DC and national influenza surveillance system, allowing for:

  • Increased awareness of seasonal influenza burden and determination of strain prevalence
  • Early detection of novel viruses or events
  • Annual vaccine strain selection
  • Antiviral resistance monitoring

Please contact us at [email protected] to learn more or to coordinate specimen submission.

Reporting Guidelines

In the District, influenza is reportable for the following cases:

  • Influenza-associated pediatric deaths (<18 years old)
  • Novel Influenza A infection
  • Any influenza outbreak

Reporting of influenza associated hospitalizations or non-pediatric deaths is strongly encouraged, but not required. No other individual cases of influenza are reportable to DOH. Cases should be submitted to DE-DSI online using DC Reporting and Surveillance Center (DCRC).

Influenza-Associated Pediatric Death Case Definition

An influenza associated pediatric death is defined as a death resulting from a clinically compatible illness that was confirmed to be influenza by an appropriate laboratory or rapid diagnostic test. There should be no period of complete recovery between the illness and death. Any such death in persons <18 years is required to be reported. Laboratory testing for influenza virus infection may be done on pre- or post-mortem clinical specimens.

A death should not be reported if:

  • There is no laboratory confirmation of influenza virus infection.
  • The influenza illness is followed by full recovery to baseline health status prior to death.
  • After review and consultation there is an alternative agreed upon cause of death.

Novel Influenza A Infection Case Definition

Novel influenza A infection is defined as a human case of infection with an influenza A virus subtype that is different from currently circulating human influenza H1 and H3 viruses. Novel subtypes include, but are not limited to, H2, H5, H7, and H9 subtypes. Influenza H1 and H3 subtypes originating from a non-human species or from genetic reassortment between animal and human viruses are also novel subtypes.

Please contact us at [email protected] with any questions about influenza reporting.